Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Fresh Tracks Therapeutics, Inc.VICL · Entity 90076 | Director | May 23, 2018 | May 24, 2018 |
| Kadmon Holdings, Inc.KDMN · Entity 133686 | Director | June 29, 2017 | June 30, 2017 |
| MeiraGTx Holdings plcMGTX · Entity 4734 | Director | June 11, 2026 | June 16, 2026 |
| Merck & Co., Inc.MRK · Entity 2807 | Director | May 27, 2011 | May 31, 2011 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Fresh Tracks Therapeutics, Inc.
Report date May 23, 2018 · Filed May 24, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Nonstatutory Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.67 · Expires 2028-05-22 | Direct | 6,500 |
Reported balance
After 2018-05-23 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2018-05-23 · Grant · Acquired 6,500 · Balance 6,500 F1: The date in this field is approximate. These options are exercisable at the date of the next annual meeting of stockholders. The date of the meeting has not been set, but is expected to occur in May 2019. |
Filing footnotes · ownership attribution and instrument terms
F1: The date in this field is approximate. These options are exercisable at the date of the next annual meeting of stockholders. The date of the meeting has not been set, but is expected to occur in May 2019.
Kadmon Holdings, Inc.
Report date June 29, 2017 · Filed June 30, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $4.12 · Expires 2027-06-29 | Direct | 25,000 |
Reported balance
After 2017-06-29 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2017-06-29 · Grant · Acquired 25,000 · Balance 25,000 F1: The option becomes vested and exercisable on June 29, 2018. F2: Only represents derivative securities of this class. |
Filing footnotes · ownership attribution and instrument terms
F1: The option becomes vested and exercisable on June 29, 2018.
F2: Only represents derivative securities of this class.
MeiraGTx Holdings plc
Report date June 11, 2026 · Filed June 16, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Share UnitsSEC Table II · derivative / convertible security | Direct | 69,662 |
Reported balance
After 2026-06-11 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-06-11 · Grant · Acquired 69,662 · Balance 69,662 F1: Each restricted share unit converts into one ordinary share upon settlement. The reporting person elected to have the restricted share units become settleable when the reporting person ceases to be a director. F2: The restricted share units shall vest in a single annual installment upon the earlier of (i) June 11, 2027 or (ii) the day immediately prior to the date of the Issuer's annual meeting of shareholders in 2027. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted share unit converts into one ordinary share upon settlement. The reporting person elected to have the restricted share units become settleable when the reporting person ceases to be a director.
F2: The restricted share units shall vest in a single annual installment upon the earlier of (i) June 11, 2027 or (ii) the day immediately prior to the date of the Issuer's annual meeting of shareholders in 2027.
Merck & Co., Inc.
Report date May 27, 2011 · Filed May 31, 2011
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Phantom StockSEC Table II · derivative / convertible security | Direct | 16,484.5871 |
Reported balance
After 2011-05-27 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2011-05-27 · Grant · Acquired 4,142.5021 · Balance 16,484.5871 F1: 1-for-1 F2: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3: Holdings include shares acquired in dividend reinvestment transactions. |
| Common StockSEC Table I · non-derivative | Direct | 1,000 |
Reported balance
Holding disclosure · report date 2011-05-27 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 1,000 |
Filing footnotes · ownership attribution and instrument terms
F1: 1-for-1
F2: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation.
F3: Holdings include shares acquired in dividend reinvestment transactions.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 11, 2026 Filed Jun 16, 2026 00:55 UTC | MeiraGTx Holdings plc MGTX · Entity 4734 | GrantRestricted Share Units · Derivative | 69,662 | $0.00 | $0.00 |
DisclosureSEC source: 0001204362-26-000002 · form4-06162026_120643.xml · derivative · entry 1 SHENK THOMAS E · CIK 0001204362 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 69,662 Underlying: Ordinary Shares · 69,662 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted share unit converts into one ordinary share upon settlement. The reporting person elected to have the restricted share units become settleable when the reporting person ceases to be a director. F2 · derivative.exercise_date: The restricted share units shall vest in a single annual installment upon the earlier of (i) June 11, 2027 or (ii) the day immediately prior to the date of the Issuer's annual meeting of shareholders in 2027. F2 · derivative.expiration_date: The restricted share units shall vest in a single annual installment upon the earlier of (i) June 11, 2027 or (ii) the day immediately prior to the date of the Issuer's annual meeting of shareholders in 2027. Read SEC document |
| June 12, 2025 Filed Jun 17, 2025 01:13 UTC | MeiraGTx Holdings plc MGTX · Entity 4734 | GrantRestricted Share Units · Derivative | 45,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-017458 · form4-06172025_010651.xml · derivative · entry 1 SHENK THOMAS E · CIK 0001204362 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,000 Underlying: Ordinary Shares · 45,000 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted share unit converts into one ordinary share upon settlement. The reporting person elected to have the restricted share units become settleable when the reporting person ceases to be a director. F2 · derivative.exercise_date: The restricted share units shall vest in a single annual installment upon the earlier of (i) June 12, 2026 or (ii) the day immediately prior to the date of the Issuer's annual meeting of shareholders in 2026. F2 · derivative.expiration_date: The restricted share units shall vest in a single annual installment upon the earlier of (i) June 12, 2026 or (ii) the day immediately prior to the date of the Issuer's annual meeting of shareholders in 2026. Read SEC document |
| June 06, 2024 Filed Jun 6, 2024 20:43 UTC | MeiraGTx Holdings plc MGTX · Entity 4734 | GrantRestricted Share Units · Derivative | 45,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-015782 · form4-06062024_080627.xml · derivative · entry 1 SHENK THOMAS E · CIK 0001204362 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,000 Underlying: Ordinary Shares · 45,000 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted share unit converts into one ordinary share upon settlement. The reporting person elected to have the restricted share units become settleable when the reporting person ceases to be a director. F2 · derivative.exercise_date: The restricted share units shall vest in a single annual installment upon the earlier of (i) June 6, 2025 or (ii) the day immediately prior to the date of the Issuer's annual meeting of shareholders in 2025. F2 · derivative.expiration_date: The restricted share units shall vest in a single annual installment upon the earlier of (i) June 6, 2025 or (ii) the day immediately prior to the date of the Issuer's annual meeting of shareholders in 2025. Read SEC document |
| June 08, 2023 Filed Jun 9, 2023 12:50 UTC | MeiraGTx Holdings plc MGTX · Entity 4734 | GrantRestricted Share Units · Derivative | 20,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-009474 · form4-06092023_120650.xml · derivative · entry 2 SHENK THOMAS E · CIK 0001204362 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,000 Underlying: Ordinary Shares · 20,000 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted share unit converts into one ordinary share upon settlement. The reporting person elected to have the restricted share units become settleable when the reporting person ceases to be a director. F3 · derivative.exercise_date: The restricted share units shall vest in a single annual installment upon the earlier of (i) June 8, 2024 or (ii) the day immediately prior to the date of the Issuer's annual meeting of shareholders in 2024. F3 · derivative.expiration_date: The restricted share units shall vest in a single annual installment upon the earlier of (i) June 8, 2024 or (ii) the day immediately prior to the date of the Issuer's annual meeting of shareholders in 2024. Read SEC document |
| June 08, 2023 Filed Jun 9, 2023 12:50 UTC | MeiraGTx Holdings plc MGTX · Entity 4734 | GrantStock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $8.04 | $0.00 |
DisclosureSEC source: 0001415889-23-009474 · form4-06092023_120650.xml · derivative · entry 1 SHENK THOMAS E · CIK 0001204362 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,000 Underlying: Ordinary Shares · 20,000 shares Expires 2033-06-08 F1 · derivative.exercise_date: The option shall vest and become exercisable in a single annual installment upon the earlier of (i) June 8, 2024 or (ii) the day immediately prior to the date of the Issuer's annual meeting of shareholders in 2024. Read SEC document |
| June 07, 2022 Filed Jun 9, 2022 21:01 UTC | MeiraGTx Holdings plc MGTX · Entity 4734 | GrantRestricted Share Units · Derivative | 15,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-006390 · form4-06092022_020647.xml · derivative · entry 2 SHENK THOMAS E · CIK 0001204362 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Ordinary Shares · 15,000 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted share unit converts into one ordinary share upon settlement. The reporting person elected to have the restricted share units become settleable when the reporting person ceases to be a director. F3 · derivative.exercise_date: The restricted share units shall vest in a single annual installment upon the earlier of (i) June 7, 2023 or (ii) the day immediately prior to the date of the Issuer's annual meeting of shareholders in 2023. F3 · derivative.expiration_date: The restricted share units shall vest in a single annual installment upon the earlier of (i) June 7, 2023 or (ii) the day immediately prior to the date of the Issuer's annual meeting of shareholders in 2023. Read SEC document |
| June 07, 2022 Filed Jun 9, 2022 21:01 UTC | MeiraGTx Holdings plc MGTX · Entity 4734 | GrantStock Option (right to buy) · Derivative | 15,000 | $0.00 Strike: $8.25 | $0.00 |
DisclosureSEC source: 0001415889-22-006390 · form4-06092022_020647.xml · derivative · entry 1 SHENK THOMAS E · CIK 0001204362 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Ordinary Shares · 15,000 shares Expires 2032-06-07 F1 · derivative.exercise_date: The option shall vest and become exercisable in a single annual installment upon the earlier of (i) June 7, 2023 or (ii) the day immediately prior to the date of the Issuer's annual meeting of shareholders in 2023. Read SEC document |
| June 10, 2021 Filed Jun 14, 2021 20:53 UTC | MeiraGTx Holdings plc MGTX · Entity 4734 | GrantRestricted Share Units · Derivative | 15,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-006665 · edgar.xml · derivative · entry 2 SHENK THOMAS E · CIK 0001204362 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Ordinary Shares · 15,000 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted share unit converts into one ordinary share upon settlement. The restricted share units become settleable when the reporting person ceases to be a director. F3 · derivative.exercise_date: The restricted share units shall vest in a single annual installment upon the earlier of (i) June 10, 2022 or (ii) the day immediately prior to the date of the Issuer's annual meeting of shareholders in 2022. F3 · derivative.expiration_date: The restricted share units shall vest in a single annual installment upon the earlier of (i) June 10, 2022 or (ii) the day immediately prior to the date of the Issuer's annual meeting of shareholders in 2022. Read SEC document |
| June 10, 2021 Filed Jun 14, 2021 20:53 UTC | MeiraGTx Holdings plc MGTX · Entity 4734 | GrantStock Option (right to buy) · Derivative | 15,000 | $0.00 Strike: $14.88 | $0.00 |
DisclosureSEC source: 0001179110-21-006665 · edgar.xml · derivative · entry 1 SHENK THOMAS E · CIK 0001204362 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Ordinary Shares · 15,000 shares Expires 2031-06-09 F1 · derivative.exercise_date: The option shall vest and become exercisable in a single annual installment upon the earlier of (i) June 10, 2022 or (ii) the day immediately prior to the date of the Issuer's annual meeting of shareholders in 2022. Read SEC document |
| July 20, 2020 Filed Jul 22, 2020 21:39 UTC | MeiraGTx Holdings plc MGTX · Entity 4734 | SaleOrdinary Shares | 6,667 | $15.00 | $100,005.00 |
DisclosureSEC source: 0000899243-20-020055 · doc4.xml · nonDerivative · entry 1 SHENK THOMAS E · CIK 0001204362 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 157,476 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 27, 2019. F2 · balance_after: The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $15.00 to $15.025, inclusive. F3 · balance_after: The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. F4 · ownership.nature: Represents securities held of record by Double Epiphany, LLC ("Double Epiphany"). The reporting person is a managing member of Double Epiphany and has full voting and investment power with respect to the shares held by Double Epiphany. The reporting person disclaims beneficial ownership of such shares except to the extent of any pecuniary interest therein. Read SEC document |
| June 02, 2020 Filed Jun 4, 2020 21:01 UTC | MeiraGTx Holdings plc MGTX · Entity 4734 | GrantStock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $13.85 | $0.00 |
DisclosureSEC source: 0000899243-20-015268 · doc4.xml · derivative · entry 1 SHENK THOMAS E · CIK 0001204362 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Ordinary Shares · 25,000 shares Expires 2030-06-01 F1 · derivative.exercise_date: The option shall vest and become exercisable in a single annual installment upon the earlier of (i) June 2, 2021 or (ii) the day immediately prior to the date of the Issuer's annual meeting of shareholders in 2021. Read SEC document |
| May 11, 2020 Filed May 13, 2020 21:37 UTC | MeiraGTx Holdings plc MGTX · Entity 4734 | SaleOrdinary Shares | 2,184 | $15.00 | $32,760.00 |
DisclosureSEC source: 0000899243-20-013012 · doc4.xml · nonDerivative · entry 1 SHENK THOMAS E · CIK 0001204362 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 164,143 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 27, 2019. F2 · ownership.nature: Represents securities held of record by Double Epiphany, LLC ("Double Epiphany"). The reporting person is a managing member of Double Epiphany and has full voting and investment power with respect to the shares held by Double Epiphany. The reporting person disclaims beneficial ownership of such shares except to the extent of any pecuniary interest therein. Read SEC document |
| April 20, 2020 Filed Apr 22, 2020 21:00 UTC | MeiraGTx Holdings plc MGTX · Entity 4734 | SaleOrdinary Shares | 4,482 | $15.00 | $67,230.00 |
DisclosureSEC source: 0000899243-20-011161 · doc4.xml · nonDerivative · entry 1 SHENK THOMAS E · CIK 0001204362 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 166,327 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 27, 2019. F2 · ownership.nature: Represents securities held of record by Double Epiphany, LLC ("Double Epiphany"). The reporting person is a managing member of Double Epiphany and has full voting and investment power with respect to the shares held by Double Epiphany. The reporting person disclaims beneficial ownership of such shares except to the extent of any pecuniary interest therein. Read SEC document |
| June 19, 2019 Filed Jun 21, 2019 20:16 UTC | MeiraGTx Holdings plc MGTX · Entity 4734 | GrantStock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $21.28 | $0.00 |
DisclosureSEC source: 0000899243-19-017803 · doc4.xml · derivative · entry 1 SHENK THOMAS E · CIK 0001204362 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Ordinary Shares · 25,000 shares Expires 2029-06-19 F1 · derivative.exercise_date: The option shall vest and become exercisable in a single annual installment upon the earlier of (i) June 19, 2020 or (ii) the day immediately prior to the date of the Issuer's annual meeting of shareholders in 2020. Read SEC document |
| May 23, 2018 Filed May 24, 2018 11:26 UTC | Fresh Tracks Therapeutics, Inc. VICL · Entity 90076 | GrantNonstatutory Stock Option (right to buy) · Derivative | 6,500 | $0.00 Strike: $1.67 | $0.00 |
DisclosureSEC source: 0001209191-18-032831 · doc4.xml · derivative · entry 1 SHENK THOMAS E · CIK 0001204362 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,500 Underlying: Common Stock, $.01 par value · 6,500 shares Expires 2028-05-22 F1 · derivative.exercise_date: The date in this field is approximate. These options are exercisable at the date of the next annual meeting of stockholders. The date of the meeting has not been set, but is expected to occur in May 2019. Read SEC document |
| June 29, 2017 Filed Jun 30, 2017 22:54 UTC | Kadmon Holdings, Inc. KDMN · Entity 133686 | GrantStock Option (right to buy) · Derivative | 25,000 | $4.12 Strike: $4.12 | $103,000.00 |
DisclosureSEC source: 0001593968-17-000848 · primary_01.xml · derivative · entry 1 SHENK THOMAS E · CIK 0001204362 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock, par value $0.001 · 25,000 shares Expires 2027-06-29 F1 · derivative.exercise_date: The option becomes vested and exercisable on June 29, 2018. F2 · balance_after: Only represents derivative securities of this class. Read SEC document |
| May 25, 2017 Filed May 31, 2017 15:09 UTC | Fresh Tracks Therapeutics, Inc. VICL · Entity 90076 | GrantNonstatutory Stock Option (right to buy) · Derivative | 6,500 | $0.00 Strike: $2.36 | $0.00 |
DisclosureSEC source: 0001209191-17-036388 · doc4.xml · derivative · entry 1 SHENK THOMAS E · CIK 0001204362 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,500 Underlying: Common Stock, $.01 par value · 6,500 shares Expires 2027-05-24 F1 · derivative.exercise_date: The date in this field is approximate. These options are exercisable at the date of the next annual meeting of stockholders. The date of the meeting has not been set, but is expected to occur in May 2018. Read SEC document |
| December 15, 2016 Filed Dec 17, 2016 01:27 UTC | Kadmon Holdings, Inc. KDMN · Entity 133686 | GrantStock Option (right to buy) · Derivative | 3,077 | $4.66 Strike: $4.66 | $14,338.82 |
DisclosureSEC source: 0001593968-16-001354 · primary_01.xml · derivative · entry 1 SHENK THOMAS E · CIK 0001204362 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,077 Underlying: Common Stock, par value $0.001 · 3,077 shares Expires 2026-12-15 F1 · derivative.exercise_date: The option becomes vested and exercisable on December 15, 2017. F2 · balance_after: Only represents derivative securities of this class. Read SEC document |
| May 27, 2011 Filed May 31, 2011 14:46 UTC | Merck & Co., Inc. MRK · Entity 2807 | GrantPhantom Stock · Derivative | 4,142.5021 | $36.21 | $150,000.00 |
DisclosureSEC source: 0001225208-11-015343 · doc4.xml · derivative · entry 2 SHENK THOMAS E · CIK 0001204362 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,484.5871 Underlying: Common Stock · 4,142.5021 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| August 04, 2010 Filed Aug 6, 2010 14:57 UTC | Merck & Co., Inc. MRK · Entity 2807 | GrantStock Option (right to buy) · Derivative | 5,000 | $0.00 Strike: $35.19 | $0.00 |
DisclosureSEC source: 0001225208-10-018707 · doc4.xml · derivative · entry 2 SHENK THOMAS E · CIK 0001204362 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2020-08-03 F1 · derivative.exercise_date: The option vests in three equal annual installments beginning August 4, 2011. Read SEC document |
| May 28, 2010 Filed Jun 1, 2010 20:02 UTC | Merck & Co., Inc. MRK · Entity 2807 | GrantPhantom Stock · Derivative | 1,632.5319 | $33.69 | $55,000.00 |
DisclosureSEC source: 0001225208-10-014301 · doc4.xml · derivative · entry 2 SHENK THOMAS E · CIK 0001204362 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,830.9209 Underlying: Common Stock · 1,632.5319 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| November 03, 2009 Filed Nov 6, 2009 02:36 UTC | Merck & Co., Inc. MRK · Entity 2807 | GrantStock Option (right to buy) · Derivative | 5,000 | $0.00 Strike: $24.30 | $0.00 |
DisclosureSEC source: 0001225208-09-021806 · doc4.xml · derivative · entry 11 SHENK THOMAS E · CIK 0001204362 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2019-04-30 F3 · price: This option, which vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger. Read SEC document |
| November 03, 2009 Filed Nov 6, 2009 02:36 UTC | Merck & Co., Inc. MRK · Entity 2807 | GrantStock Option (right to buy) · Derivative | 5,000 | $0.00 Strike: $38.04 | $0.00 |
DisclosureSEC source: 0001225208-09-021806 · doc4.xml · derivative · entry 10 SHENK THOMAS E · CIK 0001204362 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2018-04-29 F3 · price: This option, which vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger. Read SEC document |
| November 03, 2009 Filed Nov 6, 2009 02:36 UTC | Merck & Co., Inc. MRK · Entity 2807 | GrantStock Option (right to buy) · Derivative | 5,000 | $0.00 Strike: $51.86 | $0.00 |
DisclosureSEC source: 0001225208-09-021806 · doc4.xml · derivative · entry 9 SHENK THOMAS E · CIK 0001204362 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2017-04-26 F3 · price: This option, which vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger. Read SEC document |
| November 03, 2009 Filed Nov 6, 2009 02:36 UTC | Merck & Co., Inc. MRK · Entity 2807 | GrantStock Option (right to buy) · Derivative | 5,000 | $0.00 Strike: $34.44 | $0.00 |
DisclosureSEC source: 0001225208-09-021806 · doc4.xml · derivative · entry 8 SHENK THOMAS E · CIK 0001204362 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2016-04-27 F3 · price: This option, which vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger. Read SEC document |
| November 03, 2009 Filed Nov 6, 2009 02:36 UTC | Merck & Co., Inc. MRK · Entity 2807 | GrantStock Option (right to buy) · Derivative | 5,000 | $0.00 Strike: $33.83 | $0.00 |
DisclosureSEC source: 0001225208-09-021806 · doc4.xml · derivative · entry 7 SHENK THOMAS E · CIK 0001204362 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2015-04-28 F3 · price: This option, which vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger. Read SEC document |
| November 03, 2009 Filed Nov 6, 2009 02:36 UTC | Merck & Co., Inc. MRK · Entity 2807 | GrantStock Option (right to buy) · Derivative | 5,275 | $0.00 Strike: $71.30 | $0.00 |
DisclosureSEC source: 0001225208-09-021806 · doc4.xml · derivative · entry 6 SHENK THOMAS E · CIK 0001204362 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,275 Underlying: Common Stock · 5,275 shares Expires 2011-04-26 F4 · price: This option, which vesting on the exercisable date, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger. Read SEC document |
| November 03, 2009 Filed Nov 6, 2009 02:36 UTC | Merck & Co., Inc. MRK · Entity 2807 | GrantStock Option (right to buy) · Derivative | 5,000 | $0.00 Strike: $47.23 | $0.00 |
DisclosureSEC source: 0001225208-09-021806 · doc4.xml · derivative · entry 5 SHENK THOMAS E · CIK 0001204362 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2014-04-29 F3 · price: This option, which vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger. Read SEC document |
| November 03, 2009 Filed Nov 6, 2009 02:36 UTC | Merck & Co., Inc. MRK · Entity 2807 | GrantStock Option (right to buy) · Derivative | 5,275 | $0.00 Strike: $53.84 | $0.00 |
DisclosureSEC source: 0001225208-09-021806 · doc4.xml · derivative · entry 4 SHENK THOMAS E · CIK 0001204362 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,275 Underlying: Common Stock · 5,275 shares Expires 2013-04-27 F3 · price: This option, which vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger. Read SEC document |
| November 03, 2009 Filed Nov 6, 2009 02:36 UTC | Merck & Co., Inc. MRK · Entity 2807 | GrantStock Option (right to buy) · Derivative | 5,275 | $0.00 Strike: $51.60 | $0.00 |
DisclosureSEC source: 0001225208-09-021806 · doc4.xml · derivative · entry 3 SHENK THOMAS E · CIK 0001204362 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,275 Underlying: Common Stock · 5,275 shares Expires 2012-04-25 F3 · price: This option, which vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger. Read SEC document |
| November 03, 2009 Filed Nov 6, 2009 02:36 UTC | Merck & Co., Inc. MRK · Entity 2807 | GrantPhantom Stock · Derivative | 9,993.3995 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001225208-09-021806 · doc4.xml · derivative · entry 2 SHENK THOMAS E · CIK 0001204362 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,993.3995 Underlying: Common Stock · 9,993.3995 shares Expires not disclosed F2 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of Merck & Co., Inc. Common Stock, pursuant to the Plan for Deferred Payment of Directors Compensation, and was exchanged for an equal number of shares of phantom stock of MSD in connection with the Transactions. F2 · derivative.exercise_date: Each share of phantom stock is the economic equivalent of one share of Merck & Co., Inc. Common Stock, pursuant to the Plan for Deferred Payment of Directors Compensation, and was exchanged for an equal number of shares of phantom stock of MSD in connection with the Transactions. F2 · derivative.expiration_date: Each share of phantom stock is the economic equivalent of one share of Merck & Co., Inc. Common Stock, pursuant to the Plan for Deferred Payment of Directors Compensation, and was exchanged for an equal number of shares of phantom stock of MSD in connection with the Transactions. Read SEC document |
| November 03, 2009 Filed Nov 6, 2009 02:36 UTC | Merck & Co., Inc. MRK · Entity 2807 | GrantCommon Stock | 1,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-09-021806 · doc4.xml · nonDerivative · entry 1 SHENK THOMAS E · CIK 0001204362 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,000 F1 · price: Received in exchange for an equivalent number of shares of Merck Sharp & Dohme Corp. (formerly Merck & Co., Inc.) ("MSD") common stock in connection with the completion of transactions contemplated by the Agreement and Plan of Merger by and among, inter alia, MSD and Merck & Co., Inc. (formerly Schering-Plough Corporation) (the "Transactions"). Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.